share_log

Needham Reiterates Buy on Trevi Therapeutics, Maintains $8 Price Target

Needham Reiterates Buy on Trevi Therapeutics, Maintains $8 Price Target

Needham重申買入Trevi Therapeutics,維持8美元的目標股價
Moomoo 24/7 ·  03/21 06:53

Needham analyst Serge Belanger reiterates Trevi Therapeutics (NASDAQ:TRVI) with a Buy and maintains $8 price target.

Needham分析師塞爾吉·貝蘭格重申Trevi Therapeutics(納斯達克股票代碼:TRVI)的買入並維持8美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論